These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Treatment pathways in an inception lupus cohort over the first three years. Hanly JG; Sayani A; Doucette S; Iczkovitz S; Terres JAR Lupus; 2017 Feb; 26(2):119-124. PubMed ID: 27365369 [TBL] [Abstract][Full Text] [Related]
5. Synergistic effect of cumulative corticosteroid dose and immunosuppressants on avascular necrosis in patients with systemic lupus erythematosus. Kwon HH; Bang SY; Won S; Park Y; Yi JH; Joo YB; Lee HS; Bae SC Lupus; 2018 Sep; 27(10):1644-1651. PubMed ID: 29950160 [TBL] [Abstract][Full Text] [Related]
6. Damage in systemic lupus erythematosus and its association with corticosteroids. Zonana-Nacach A; Barr SG; Magder LS; Petri M Arthritis Rheum; 2000 Aug; 43(8):1801-8. PubMed ID: 10943870 [TBL] [Abstract][Full Text] [Related]
7. Complete urological evaluation including sperm DNA fragmentation in male systemic lupus erythematosus patients. Tiseo BC; Bonfá E; Borba EF; Munhoz GA; Wood G; Srougi M; Silva CA; Cocuzza M Lupus; 2019 Jan; 28(1):59-65. PubMed ID: 30509155 [TBL] [Abstract][Full Text] [Related]
8. Lupus nephritis is associated with more corticosteroid-associated organ damage but less corticosteroid non-associated organ damage. Joo YB; Won S; Choi CB; Bae SC Lupus; 2017 May; 26(6):598-605. PubMed ID: 27687027 [TBL] [Abstract][Full Text] [Related]
9. Anti-Sm Antibody, Damage Index, and Corticosteroid Use Are Associated with Cardiac Involvement in Systemic Lupus Erythematosus: Data from a Prospective Registry Study. Choe JY; Lee SS; Kwak SG; Kim SK J Korean Med Sci; 2020 Jun; 35(21):e139. PubMed ID: 32476300 [TBL] [Abstract][Full Text] [Related]
10. Cerebral atrophy related to corticotherapy in systemic lupus erythematosus (SLE). Zanardi VA; Magna LA; Costallat LT Clin Rheumatol; 2001; 20(4):245-50. PubMed ID: 11529629 [TBL] [Abstract][Full Text] [Related]
11. Evaluation of risk factors that contribute to high prevalence of premature atherosclerosis in Chinese premenopausal systemic lupus erythematosus patients. Zhang CY; Lu LJ; Li FH; Li HL; Gu YY; Chen SL; Bao CD J Clin Rheumatol; 2009 Apr; 15(3):111-6. PubMed ID: 19300290 [TBL] [Abstract][Full Text] [Related]
12. The GLADEL multinational Latin American prospective inception cohort of 1,214 patients with systemic lupus erythematosus: ethnic and disease heterogeneity among "Hispanics". Pons-Estel BA; Catoggio LJ; Cardiel MH; Soriano ER; Gentiletti S; Villa AR; Abadi I; Caeiro F; Alvarellos A; Alarcón-Segovia D; Medicine (Baltimore); 2004 Jan; 83(1):1-17. PubMed ID: 14747764 [TBL] [Abstract][Full Text] [Related]
13. Time to diagnosis in systemic lupus erythematosus: Associated factors and its impact on damage accrual and mortality. Data from a multi-ethnic, multinational Latin American lupus cohort. Nieto R; Quintana R; Zavala-Flores E; Serrano R; Roberts K; Catoggio LJ; García MA; Berbotto GA; Saurit V; Bonfa E; Borba EF; Lavras Costallat LT; Da Silva NA; Sato EI; Tavares Brenol JC; Massardo L; Neira OJ; Vázquez G; Guibert Toledano M; Pascual-Ramos V; Sauza Del Pozo MJ; Barile-Fabris LA; Amigo MC; García De La Torre I; Acevedo-Vásquez EM; Segami MI; Chacón-Díaz R; Esteva-Spinetti MH; Alarcón GS; Pons-Estel BA; Pons-Estel GJ Lupus; 2024 Apr; 33(4):340-346. PubMed ID: 38334100 [TBL] [Abstract][Full Text] [Related]
14. Survival analysis of patients with systemic lupus erythematosus in a tertiary hospital in southern Brazil. Hendler JV; de Souza L; de Freitas Zernow DC; Guimarães J; Bertotto T; Saldanha CF; Brenol JCT; Monticielo OA Clin Rheumatol; 2017 Sep; 36(9):2005-2010. PubMed ID: 28653264 [TBL] [Abstract][Full Text] [Related]
15. Clinical outcomes and risk factors for posterior reversible encephalopathy syndrome in systemic lupus erythematosus: a multicentric case-control study. Merayo-Chalico J; Apodaca E; Barrera-Vargas A; Alcocer-Varela J; Colunga-Pedraza I; González-Patiño A; Arauz A; Abud-Mendoza C; Martínez-Martínez M; Gómez-Martín D J Neurol Neurosurg Psychiatry; 2016 Mar; 87(3):287-94. PubMed ID: 25804426 [TBL] [Abstract][Full Text] [Related]
16. Lymphopenia as risk factor for development of severe infections in patients with systemic lupus erythematosus: a case-control study. Merayo-Chalico J; Gómez-Martín D; Piñeirúa-Menéndez A; Santana-De Anda K; Alcocer-Varela J QJM; 2013 May; 106(5):451-7. PubMed ID: 23458779 [TBL] [Abstract][Full Text] [Related]
17. Risk factors and clinical profile of thrombotic thrombocytopenic purpura in systemic lupus erythematosus patients. Is this a distinctive clinical entity in the thrombotic microangiopathy spectrum?: a case control study. Merayo-Chalico J; Demichelis-Gómez R; Rajme-López S; Aparicio-Vera L; Barrera-Vargas A; Alcocer-Varela J; Gómez-Martín D Thromb Res; 2014 Nov; 134(5):1020-7. PubMed ID: 25257921 [TBL] [Abstract][Full Text] [Related]
18. Lymphopenia as a risk factor for neurologic involvement and organ damage accrual in patients with systemic lupus erythematosus: A multi-center observational study. Yavuz S; Cansu DU; Nikolopoulos D; Crisafulli F; Antunes AM; Adamichou C; Reid S; Stagnaro C; Andreoli L; Tincani A; Moraes-Fontes MF; Mosca M; Leonard D; Jönsen A; Bengtsson A; Svenungsson E; Gunnarsson I; Dahlqvist SR; Sjöwall C; Bertsias G; Fanouriakis A; Rönnblom L Semin Arthritis Rheum; 2020 Dec; 50(6):1387-1393. PubMed ID: 32229040 [TBL] [Abstract][Full Text] [Related]
19. Systemic lupus erythematosus in a multiethnic US cohort, XXXVII: association of lymphopenia with clinical manifestations, serologic abnormalities, disease activity, and damage accrual. Vilá LM; Alarcón GS; McGwin G; Bastian HM; Fessler BJ; Reveille JD; Arthritis Rheum; 2006 Oct; 55(5):799-806. PubMed ID: 17013840 [TBL] [Abstract][Full Text] [Related]